Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1170 |
|---|---|
| Identifier | NCT05471492 |
| Trial Title | Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Investigational Product|DRUG: Placebo |
Participant Information
| Sponsor | Telavant, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-07-30 |
|---|---|
| Primary Completion Date | 2026-08-15 |
| Completion Date | 2026-08-15 |